Internal Server Error

About Health Catalyst Capital

Health Catalyst Capital is a venture capital firm founded in 2015. It is primarily based out of New York City, United States. As of Sep 2023, Health Catalyst Capital has invested in 33 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series B round of Cylinder Health Overall, Health Catalyst Capital portfolio has seen 11 acquisitions including key companies like Holmusk, Artemis Health and PierianDx. A lot of funds co-invest with Health Catalyst Capital, with names like Optum Ventures sharing a substantial percentage of its portfolio. Health Catalyst Capital has team of 21 people including 1 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed, Series B & 3 more
Portfolio Acquisitions
Portfolio Soonicorns

Health Catalyst Capital's List of Top Investments

Health Catalyst Capital has a portfolio of 33 companies. Their most notable investments are in Holmusk and PierianDx.Their portfolio spans across United States, India, Netherlands and 1 more locations. They have invested in Enterprise Applications, HealthTech, Life Sciences and 10 other sectors, across stages such as Seed, Series B  and 3 more. Here is the list of top investments by Health Catalyst Capital:
Provider of technology and services for healthcare member engagement and quality. The company offers a platform to consolidate member engagement, risk, and quality initiatives. It facilitates personalized, omnichannel outreach and supports digital health risk assessments. The company also provides professional and expert advisory services.

Key facts about HealthMine

Provider of a platform for healthcare professionals to access patient data securely. The solution provides access to patient information, the medical professionals can compare their data to only exchange the records needed.

Key facts about Datavant

AI-based digital health solutions and data analytics for providers. The platform NeuroBlu monitors the user's data and the prediction engine recommends lifestyle changes before the condition worsens. The proprietary analytical tools work on real-world data to recognize disease progression. The EHR system is designed to capture and monitor decisions and is combined with past mental health records. It also enables data-driven research and development providing evidence for regulatory submission.

Key facts about Holmusk

  • Founded Year: 2015
  • Location: Singapore (Singapore)
  • Annual Revenue: 2.28M SGD as on Mar 31, 2020
  • Last Known Valuation: $*****
  • Stage: Acquired
  • Total Funding till date: $109M
  • Employee Count: 89 as on Apr 30, 2026
  • Investors: Optum Ventures, Start2 and 37 Others
  • Latest Funding Round: Series B, Oct 12, 2023, $*****
  • Highlight: Acquired
Developer of a platform for recording, editing, and sharing game clips. The platform allows users to capture gameplay with a button press and share instantly. It supports automatic clipping for various games and allows importing clips from console systems. The platform offers editing tools, multi-track audio balancing, and customizable clip lengths.

Key facts about Medal

Digital health platform offering solutions for individuals with digestive health issues. It provides care for various digestive health issues, offering individualized care plans designed to address specific symptoms and needs. It offers customized care plans for digestive health needs, virtual access to a dedicated team of doctors, Registered Dietitians, Health Coaches, and more.

Key facts about Cylinder Health

Health Catalyst Capital's Investments by Stage

Health Catalyst Capital has made 5 investments in Seed stage with an average round size of $1.75M, 4 investments in Series B stage with an average round size of $25.3M, 3 investments in Series A stage with an average round size of $21.5M, 2 investments in Series C stage with an average round size of $50M and 1 investment in Series D stage with an average round size of $30M.
Here are Health Catalyst Capital's investments by stage:
Stage of entry
No. of Investments
Seed
5
Series B
4
Series A
3
Series C
2
Series D
1
Breakdown of Health Catalyst Capital's investments by stage of entrySeed (5)Series B (4)
Note: We have considered here, only first round of investments

Health Catalyst Capital's Investments by Sector

Health Catalyst Capital has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Vertical SaaS, Consumer and High Tech. Notably, it has invested in 31 Tech companies, 27 Enterprise (B2B) companies, 26 Software companies and at least 20 companies focusing on Saas.
Here are Health Catalyst Capital's investments by sector:
Sector
No. of Investments
HealthTech
12
Enterprise Applications
10
Vertical SaaS
6
Consumer
2
High Tech
2
Others
6
Breakdown of Health Catalyst Capital's investments by sectorsHealthTech (12)Enterprise Applic... (10)
Note: We have considered here, only first round of investments

Health Catalyst Capital's Investments by Geography

Health Catalyst Capital has made most investments in United States (13), followed by Netherlands where it has made 1 investment.
Here are Health Catalyst Capital's investments by geography:
Country
No. of Investments
United States
13
Netherlands
1
Singapore
1
Breakdown of Health Catalyst Capital's investments by countriesUnited States (13)Netherlands (1)
Note: We have considered here, only first round of investments

Health Catalyst Capital's recent investments

Health Catalyst Capital has not made any investment in 2026 so far.
Here are the most recent investments by Health Catalyst Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Sep 20, 2023
United States
Series B
8677
Jan 31, 2023
United States
Series D
3638
Jan 10, 2023
United States
Series B
6334
Jan 09, 2023
Singapore
Series B
2548
  [+3]
Dec 06, 2021
Singapore
Series A
5492

Acquired companies in Health Catalyst Capital's Portfolio

11 companies from Health Catalyst Capital's portfolio have been acquired. The most recent acquisition was Clareto in May 2025 by MIB for $*****.
Here are Health Catalyst Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
May 02, 2025
Feb 21, 2019
Series A
4585
Jan 13, 2023
2015
Seed
4806
Jul 12, 2022
May 18, 2020
Series A
3300
Jan 06, 2022
-
-
5563
Oct 24, 2021
-
-
9444

Team profile of Health Catalyst Capital

Health Catalyst Capital has a team of 21 members including 1 Partner and 1 Principal located in United States. Health Catalyst Capital's team does not sit on the board of any company as of now.

Co-investors of Health Catalyst Capital

Over the past 11 years, 114 investors have co-invested in Health Catalyst Capital's portfolio companies. This includes funds and angels.

  • Invested before Health Catalyst CapitalUncork Capital, OCTAVE Capital and 51 others have invested in rounds before Health Catalyst Capital. There are 2 companies where Uncork Capital has invested before Health Catalyst Capital and 1 company where OCTAVE Capital has invested before Health Catalyst Capital.
  • Top Co-investors of Health Catalyst Capital27 investors entered a company along with Health Catalyst Capital. These include investors like Optum Ventures (1 company).
  • Invested after Health Catalyst CapitalA total of 34 investors have invested in Health Catalyst Capital's portfolio after their investments. Top Investors include Veradigm (1 company), dRx Capital (1 company) and Northwell (1 company).

Recent News related to Health Catalyst Capital

View all news related to Health Catalyst Capital

FAQs about Health Catalyst Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford